New facility will serve as regional headquarters for Singleron in Asia
Singleron cordially invites you to our free Webinar Miniseries: Single Cell Sequencing for Every Lab.
Singleron further extends reach outside China and strengthens its expertise in translational and clinical research
Understand the basic concepts of the single cell sequencing data analysis
Singleron Biotechnologies recently completed its oversubscribed Series B financing, raising close to $100M.
Join our free webinar to get to know our new fully automated tissue dissociation system!
Discover how to use advanced single-cell multi-omics analysis tools to simultaneously analyze tumor genetic variants and microenvironment
Genomeweb article titled “China's Singleron Biotechnologies Pushes Single-Cell RNA-seq Into Clinical, Translational Studies”
Singleron will present at BioRN conference on October 1st, 2021. Where: Halle02, Zollhofgarten 2, 69115 Heidelberg
October 8-9, 2021 Virtually. "FocuSCOPE: A single cell, multi-omics solution to simultaneously analyze tumor variants and microenvironment"
Singleron will present at CMMC Symposium on September 26-28, 2021 in Cologne
Singleron has raised in A, A1, A2 about $70M in total and introduced prominent investors such as LAV, CDH, ARCH Venture Partners, CDG Capital, and Tencent as new shareholders of the company.
Singleron' products were used in a Covid-study which was recently published in Cell Research on June 16, 2021
Singleron to present two posters at LifeTime conferences.
Singleron Biotechnologies announced a drug discovery partnership with XtalPi Inc., an AI-powered pharmaceutical technology company.
Singleron Biotechnologies announced its collaboration with Agilent Technologies Inc. (NYSE: A) to accelerate the development and application of single cell sequencing technology.
Singleron completed Series A1 financing of more than $10M, following a recent Series A round that raised $30M
Singleron announced the successful completion of $30 million Series A financing led by Lilly Asia Ventures (LAV)
Report from Wuhan Huoshenshan Hospital to fight against Covid-19